US Officially Exits WHO: A Seismic Shift in Global Health Governance with Uncertain Health Ramifications

Spread the Message

Read Time:4 Minute, 23 Second

On January 22, 2026, the United States formally withdrew from the World Health Organization (WHO), marking the culmination of President Donald Trump’s executive order issued on his inauguration day in January 2025. This move, rooted in criticisms of the WHO’s handling of the COVID-19 pandemic and perceived funding inequities, ends decades of US leadership in the UN agency despite warnings of risks to both domestic and international public health. As the WHO’s largest donor, contributing around 15% of its budget, the departure raises questions about funding shortfalls, disease surveillance gaps, and future pandemic preparedness.

Timeline of the Withdrawal

The process began with Executive Order 14155, signed by President Trump on January 20, 2025, which paused US funding to the WHO, recalled American personnel, and directed the identification of alternative partners for global health activities. US law requires a one-year notice period and settlement of outstanding dues—estimated at $260 million for 2024 and 2025—before exit, though the State Department has not confirmed payment, prompting legal debates. This echoes Trump’s 2020 withdrawal attempt, reversed by the Biden administration, highlighting ongoing partisan divides over multilateral health institutions.

The WHO confirmed receipt of the notice but noted unpaid dues, with member states set to discuss implications at the February 2026 executive board meeting. Unlike the 2020 effort, this withdrawal proceeded without congressional approval hurdles, as the one-year clock expired on Thursday.

Official Reasons for Departure

The Trump administration cited the WHO’s “mishandling” of COVID-19, including alleged collusion with China and failure to share timely information, which they claim cost the US economy $14-16 trillion. Funding disparities were central: the US provided $1.28 billion for the 2022-2023 biennium (12-15% of the budget), far exceeding China’s $157 million despite its larger population. The executive order accused the WHO of lacking reforms on political influence, governance, and coordination post-pandemic.

Proponents argue this frees resources for domestic priorities and bilateral aid, avoiding what they call “unfair” burdens on American taxpayers. The administration plans to redirect efforts through “credible and transparent” US-led partners.Expert Reactions and Warnings

Health experts expressed alarm over the exit’s potential to undermine global health security. Lawrence Gostin, founding director of Georgetown University’s O’Neill Institute for Global Health Law, called it “a clear infringement of US law” but predicted no repercussions, warning of diminished US influence. WHO Director-General Tedros Adhanom Ghebreyesus stated the withdrawal “makes the world less safe,” regretting the loss of the top donor.

Dr. Tom Frieden, former CDC director and CEO of Resolve to Save Lives, argued, “Withdrawing from WHO not only cuts crucial funding but surrenders our role as a global health leader,” emphasizing reform through engagement over abandonment. Avril Benoît, CEO of Doctors Without Borders US, highlighted “life-threatening consequences” for humanitarian contexts and US interests. These voices stress the US forfeits seats on key committees shaping health regulations.

Public Health Implications

The US withdrawal threatens WHO programs reliant on American funding, including polio eradication, HIV/AIDS control, tuberculosis efforts, and maternal-child health initiatives. Loss of participation in the Global Influenza Surveillance and Response System could hinder early pandemic detection, as the WHO coordinates cross-border threat monitoring. Experts predict surges in preventable diseases, exacerbated climate-health risks like vector-borne illnesses, and stalled progress toward UN Sustainable Development Goals.

For Americans, reduced global collaboration might boomerang via imported outbreaks or weakened vaccine alliances like GAVI. Developing nations face the brunt, with disrupted aid potentially reversing gains in child mortality and infectious disease control. The WHO’s budget, already facing shortfalls, may force cuts, though other donors like Germany and the Gates Foundation could partially offset.

Broader Context and Limitations

The US joined the WHO in 1948 as a founding member, historically providing 15-16% of funds via assessed and voluntary contributions supporting emergencies, disease eradication, and health equity. Critics of the WHO acknowledge valid reform needs, such as over-reliance on earmarked voluntary funds (87% in 2022-2023), which limit flexibility. However, unilateral exit sidesteps opportunities for internal changes, like the 50% assessed funding goal by 2030.

Limitations include the administration’s unverified economic loss claims and potential for bilateral US programs to fill gaps effectively. Diverse viewpoints persist: some conservatives praise cost savings, while global health advocates decry eroded multilateralism. A quick US return seems unlikely amid political shifts.

Future Outlook

This exit signals a pivot to America First health policy, potentially inspiring similar moves by allies and reshaping governance toward bilateralism. The WHO’s February meeting will gauge funding pivots and leadership voids. For public health, the true test lies in responding to the next threat—whether influenza, mpox, or novel pathogens—without full US engagement. Healthcare professionals and consumers must monitor how redirected US resources perform amid these uncertainties.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.